Réaction #836426

ord-21d86a78f75845478226503f14da631d

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Autrethe catalyst was removed by filtration through celite
  2. 2
    Autrethe filtrate evaporated in vacuo
  3. 3
    AutreThe residue was purified on mass

Mode opératoire

4-(Benzyloxy)-7-((1R)-2-{benzyl[6-(4-phenylbutoxy)hexyl]amino}-1-hydroxyethyl)-1,3-benzothiazol-2(3H)-one (7.4 mg) was dissolved in 98% formic acid (0.5 ml)and palladium black catalyst (4 mg) added. After stirring for 8 h, the catalyst was removed by filtration through celite and the filtrate evaporated in vacuo. The residue was purified on mass directed autoprep, to give the title compound (0.51 mg). LCMS RT=2.95 min. ES+ve 459 (M+H)+

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US07402598B2uspto-grants-2008_07